3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Endometrial Neoplasms
13
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
3
Vulvar Neoplasms
2
Squamous Intraepithelial Lesions
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anus Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sezary Syndrome
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Interventions
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Homosexuality
×
Observation
×
Gynecologic
×
Clear all
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled